Patent 8709755 was granted and assigned to Bioatla Llc on April, 2014 by the United States Patent and Trademark Office.
This disclosure relates to a method of generating conditionally active biologic proteins from wild type proteins, in particular therapeutic proteins, which are reversibly or irreversibly inactivated at the wild type normal physiological conditions. For example, evolved proteins are virtually inactive at body temperature, but are active at lower temperatures.